Daslemia 50mg Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Dasatinib (50mg)
Overview Daslemia 50mg Tablet
Chronic myeloid leukemia (CML) is treated with Daslemia 50mg tablets. This medication is prescribed for patients whose CML hasn't responded to other treatments or who experience intolerable side effects from alternative therapies. Daslemia 50mg can be administered with or without food; however, consistent daily timing maximizes efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe complications. Therapeutic benefits may take weeks or months to manifest; discontinue use only upon your doctor's recommendation. Common side effects include nausea, vomiting, stomach pain, and skin rash. Increased heart rate and fluctuations in blood pressure are possible; consult your doctor if these occur. Regular blood pressure monitoring may be implemented. Avoid antacids within two hours of taking Daslemia. This medication can lower blood cell counts, increasing infection risk, necessitating regular blood tests. Inform your healthcare provider of all other medications you are taking, as interactions are possible. Daslemia is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or blurred vision develops.
Uses of Daslemia 50mg Tablet
Chronic myeloid leukemia, a type of blood malignancy
Major Benefits of Daslemia 50mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Daslemia 50mg Tablet whole; do not break, crush, or chew it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Daslemia 50mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Daslemia 50mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 50mg Daslemia Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, however, consistent timing is recommended.
How Daslemia 50mg Tablet works:
Oncasin 50mg tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Daslemia 50mg Tablet may be unsafe; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Daslemia 50mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Daslemia 50mg tablets are incompatible. Evidence indicates potential infant toxicity associated with this medication.
DrivingUNSAFE
Driving ability may be impaired by Daslemia 50mg Tablets, which can produce side effects. Exercise caution while driving if you experience dizziness or blurred vision after taking Daslemia 50mg Tablets.
KidneySAFE IF PRESCRIBED
Daslemia 50mg tablets appear to pose minimal risk for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely take Daslemia 50mg tablets without requiring any dosage modifications.
What if you forget to take Daslemia 50mg Tablet :
Omit any missed Daslemia 50mg Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Daslemia 50mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Type of Therapy | Cancer Drugs |
| Actions | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently